Rhythm Pharmaceuticals (RYTM) Prepaid Assets (2016 - 2026)

Rhythm Pharmaceuticals (RYTM) has 11 years of Prepaid Assets data on file, last reported at $26.6 million in Q1 2026.

• Prepaid Assets for Q1 2026 came in at $26.6 million, up 50.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.6 million (up 50.76% YoY), and the FY2025 annual result was $26.1 million, up 59.52% from the prior year.
• Prepaid Assets rose to $26.6 million in Q1 2026 per RYTM's latest filing, from $26.1 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $26.6 million in Q1 2026 and troughed at $7.6 million in Q3 2023.
• A 5-year average of $14.5 million and a median of $11.6 million in 2022 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets soared 195.77% in 2022, then fell 28.96% in 2023.
• A 5-year view of Prepaid Assets shows it stood at $11.8 million in 2022, then retreated by 24.36% to $8.9 million in 2023, then soared by 83.43% to $16.4 million in 2024, then jumped by 59.52% to $26.1 million in 2025, then increased by 1.87% to $26.6 million in 2026.
• Business Quant data shows RYTM's Prepaid Assets at $26.6 million in Q1 2026, $26.1 million in Q4 2025, and $23.6 million in Q3 2025.